Literature DB >> 12531323

Vaccinology: past achievements, present roadblocks and future promises.

Francis E André1.   

Abstract

Of all the branches of modern medicine, vaccinology can claim to be the one that has contributed most to the relief of human misery and the spectacular increase in life expectancy in the last two centuries. It is the only science that has eradicated an infectious disease-smallpox-responsible for 8-20% of all deaths in several European countries in the 18th century. Other disabling and lethal diseases, like poliomyelitis and measles, are targeted for eradication. Currently, it is estimated that immunization saves the lives of 3 million children a year but 2 million more lives could be saved by existing vaccines. The success of vaccines in controlling and eliminating diseases has, paradoxically, been the cause of a revival of the anti-vaccination movement which in the absence, in developed countries, of many erstwhile common infectious diseases such as diphtheria, tetanus, polio, pertussis, measles, rubella and mumps has come to believe that vaccination is not only no longer necessary but is even dangerous. This is because it accepts, as "reactions", any untoward health event that occurs after administration of a vaccine. Most vaccine "reactions", therefore, appear to be more frequent than vaccine-preventable diseases. Public Health Authorities, aware of the great value of vaccines to society, are facing an uphill battle to get them accepted by a growing proportion of so-called educated minorities, thus endangering disease elimination. Other developments, in the last two decades, that have hampered vaccine usage have been the exploding costs of research, development and manufacture of new vaccines and the emphasis still placed on therapy in preference to prevention in medicine. This has led to the erroneous perception that vaccines are expensive although they are, in most cases, more cost-effective than the popular wait-see-treat approach. A favorable trend for vaccinology has been fueled by recent major breakthroughs in the sciences of immunology, molecular biology, genomics, proteomics, physico-chemistry and computers that promise a bright future for prevention, not only of acute infectious diseases, but also treatment of conditions like chronic infections, allergy, auto-immune diseases and cancer where some malfunctioning of the immune system is thought to play a part. Vaccines are being made more user-friendly by the development of combined vaccines and less painful and invasive inoculation techniques than the traditional syringe and needle. Recent new initiatives, like the Global Alliance on Vaccines and Immunization (GAVI),which are gathering new sources of funding for vaccination, should be beneficial for vaccinology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12531323     DOI: 10.1016/s0264-410x(02)00702-8

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

1.  Genetic diversity of the Plasmodium vivax merozoite surface protein-5 locus from diverse geographic origins.

Authors:  Chaturong Putaporntip; Rachanee Udomsangpetch; Urassaya Pattanawong; Liwang Cui; Somchai Jongwutiwes
Journal:  Gene       Date:  2010-02-21       Impact factor: 3.688

2.  Imitation dynamics predict vaccinating behaviour.

Authors:  Chris T Bauch
Journal:  Proc Biol Sci       Date:  2005-08-22       Impact factor: 5.349

3.  Mucosal and systemic adjuvant activity of alphavirus replicon particles.

Authors:  Joseph M Thompson; Alan C Whitmore; Jennifer L Konopka; Martha L Collier; Erin M B Richmond; Nancy L Davis; Herman F Staats; Robert E Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-27       Impact factor: 11.205

4.  Naturally acquired IgG antibodies against the C-terminal part of Plasmodium falciparum sporozoite threonine-asparagine-rich protein in a low endemic area.

Authors:  Chittakun Suwancharoen; Chaturong Putaporntip; Thanaporn Rungruang; Somchai Jongwutiwes
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

5.  Vaccine refusal and the endgame: walking the last mile first.

Authors:  Diane S Saint-Victor; Saad B Omer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

6.  Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen.

Authors:  Joseph M Thompson; Alan C Whitmore; Herman F Staats; Robert E Johnston
Journal:  Vaccine       Date:  2008-06-09       Impact factor: 3.641

Review 7.  Overview of computational vaccinology: vaccine development through information technology.

Authors:  Nishita Vaishnav; Aparna Gupta; Sneha Paul; Georrge J John
Journal:  J Appl Genet       Date:  2014-12-23       Impact factor: 3.240

8.  Does the relative importance of MMR vaccine concerns differ by degree of parental vaccine hesitancy?: An exploratory study.

Authors:  Charitha Gowda; Sarah E Schaffer; Kristin Kopec; Arielle Markel; Amanda F Dempsey
Journal:  Hum Vaccin Immunother       Date:  2012-10-02       Impact factor: 3.452

9.  A vaccine strategy against AIDS: an HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques.

Authors:  Vincent Vieillard; Roger Le Grand; Jean Dausset; Patrice Debré
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-30       Impact factor: 11.205

10.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.